AzTrials
AzTrials

Substance Use DisordersNCT04723498

Problematic Use of the Internet in Child and Adolescent Psychiatry

A study testing screening questionnaire in people with Substance Use Disorders, run by Susanne Walitza at 1 site in Switzerland.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Pathological internet use is a blanket term for problematic behavior types (e.g. uncontrolled gaming, cyber pornography, cyber mobbing and excessive use of social media): all perpetrated through the internet. Read more about this study

Who is it for?
Ages 8 to 18 yearsHealthy volunteers can take part
Conditions the study is for
Substance Use Disorders
What is being tested?
screening questionnaire
Could I receive a placebo?
No, everyone receives an active treatment
How many people
300 participants
Where
1 siteSwitzerland
Study dates
1 Dec 2020to 1 Mar 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 18 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • male and female patients ages from 8 - 18 years
  • All study participants or their legal representative have given written permission for their experiences to be documented in the study.

Who cannot join

  • Inability to understand explanations and the questionnaire, whether linguistic or cognitative

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Susanne Walitza, Prof. Dr. med. Dipl.-Psych. contact

+41 43 499 26 26

susanne.walitza@puk.zh.ch

Renate Drechsler, Prof. Dr. phil. contact

+41 43 499 4050

renate.drechsler@kjpd.uzh.ch

Switzerland1 site, 1 recruiting
  • Psychiatric University Clinics, Department of Child and Adolescent Psychiatry

    Zurich, Canton of Zurich, 8032

    Susanne Walitza, susanne.walitza@puk.zh.ch, +41 43 499 26 26, susanne.walitza@puk.zh.ch

    Renate Drechsler, Prof. Dr. phil., +41 43 499 4050, renate.drechsler@kjpd.uzh.ch

    Recruiting

Other trials in Switzerland

About this study

Pathological internet use is a blanket term for problematic behavior types (e.g. uncontrolled gaming, cyber pornography, cyber mobbing and excessive use of social media): all perpetrated through the internet. There is little documentation or research on interdependencies/interplay between problematic internet and/or media use and child-adolescent disturbances. Very few clinical examples of syndromes like attention deficiency/hyperactivity (ADHS), anxiety disorder or affective disturbances associated with pathological media/internet use, or gaming, are found in literature.

Being tested
screening questionnaire
Medical subject headings
Substance-Related Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • screening questionnaireDiagnostic test

    Fill in screening questionnaire

Study groups in NCT04723498
Study groupRoleWhat they receive
PatientsOthermale and female patients, handled on an ambulatory basis in Psychiatric University Clinics, Department of Child and Adolescent Psychiatrythe ages from 8 - 18 years during the study
Receives: Diagnostic Test: screening questionnaire

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Symptoms severity of problematic internet and media use

    The clinician screening questionnaire (PUI) contains 9 items designed to assess severity of problematic internet and media use of obsessive and compulsive in children and adolescents.The test uses a 4-point scale to rate severity of problematic internet and media use. Higher score means a worse outcome.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Jan 2021
  2. Study start1 Dec 2020
  3. Primary completion1 Mar 2026 (estimated)
  4. Study completion1 Mar 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04723498
Sponsor's protocol ID
KJPP 2020-00117
Status last verified
May 2025
First submitted
21 Jan 2021
Last updated
13 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing screening questionnaire in people with Substance Use Disorders, run by Susanne Walitza at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 13 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Susanne Walitza, Prof. Dr. med. Dipl.-Psych. (+41 43 499 26 26, susanne.walitza@puk.zh.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Symptoms severity of problematic internet and media use (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in